FDA
-
-
-
-
-
-
-
RedHill's RHB-204 shows comparable efficacy to RHB-104 in lab tests
-
-
-
-
-
-
-
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
-
-
-
-
-
-
-
RedHill Announces $10.5 Million New York Supreme Court Judgment Win Now Final for Enforcement
-
-
-
-
-
-
-
RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
-
-
-
-
-
-
-
RedHill Biopharma Awarded $1.8 Million in Legal Costs and Expenses by New York Supreme Court in Addition to its Prior $8.25 Million Summary Judgment Win
-
-
-
-
-
-
-
RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win
-
-
-
-
-
-
-
RedHill Biopharma's Positive Opaganib Weight Loss & Diabetes Data Published: Signals Potential $100B Market Disruption
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

